Nifedipine Exacerbates Lipogenesis in the Kidney via KIM-1, CD36, and SREBP Upregulation: Implications from an Animal Model for Human Study
Dysregulation of fatty acid oxidation and accumulation of fatty acids can cause kidney injury. Nifedipine modulates lipogenesis-related transcriptional factor SREBP-1/2 in proximal tubular cells by inhibiting the Adenosine 5‘-monophosphate (AMP)-activated protein kinase (AMPK) pathway in vitro. Howe...
Main Authors: | Yen-Chung Lin, Jhih-Cheng Wang, Mai-Szu Wu, Yuh-Feng Lin, Chang-Rong Chen, Chang-Yu Chen, Kuan-Chou Chen, Chiung-Chi Peng |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/12/4359 |
Similar Items
-
CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing
by: Han Zeng, et al.
Published: (2022-03-01) -
Targeting SREBP-1-Mediated Lipogenesis as Potential Strategies for Cancer
by: Qiushi Zhao, et al.
Published: (2022-07-01) -
Cdk8 attenuates lipogenesis by inhibiting SREBP-dependent transcription in Drosophila
by: Xiao Li, et al.
Published: (2022-11-01) -
RA-XII Suppresses the Development and Growth of Liver Cancer by Inhibition of Lipogenesis via SCAP-dependent SREBP Supression
by: Di Guo, et al.
Published: (2019-05-01) -
The role of KLF2 in regulating hepatic lipogenesis and blood cholesterol homeostasis via the SCAP/SREBP pathway
by: Yuhong Huang, et al.
Published: (2024-01-01)